{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-004361","form_type":"8-K","ticker":"ZSQR","cik":"0001759186","company_name":"Z Squared Inc.","filed_at":"2024-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.927374+00:00","generated_at":"2026-06-01T03:36:37.496606+00:00","sec_items":["3.02","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Coeptis raises $4.3M in Series A Preferred financing; CEO granted 2.4M options","bullets":["Raised $4.3M via sale of 4,300 shares of Series A Preferred at $1,000/share to accredited investors.","Financing led by CJC Investment Trust (entity of board member Christopher Calise).","Series A convertible at $0.40/share; automatic conversion upon $20M+ fundraising.","CEO David Mehalick granted options for 2.4M shares (fully vested, 10-year term) on June 13.","Investors also received 6.45% non-voting equity in new subsidiaries SNAP Biosciences and GEAR Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-004361","json":"https://secwatch.observer/filing/0001683168-24-004361.json","markdown":"https://secwatch.observer/filing/0001683168-24-004361.md","text":"https://secwatch.observer/filing/0001683168-24-004361.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759186/000168316824004361/0001683168-24-004361-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759186/000168316824004361/coeptis_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:36:37.496606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}